According to a review of the safety and effectiveness of a commonly-used corneal transplant procedure that was highlighted by September’s Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), the use of systematic fluoroquinolones, a class of antibiotics used to treat a variety of bacterial infections can lead to double vision.

It was highlighted that fluoroquinolones when administered in a systemic manner for curing a vast range of bacterial infections can lead to double vision (diplopia) in some of the administered patients.

From News-Medical.net:

The researchers, led by Frederick W. Fraunfelder, M.D., found 171 cases between 1986 and 2009 of fluoroquinolone use associated with double vision through a review of reports from the Food and Drug Administration, World Health Organization, and the National Registry of Drug-Induced Ocular Side Effects. The median patient age was 51.6 years, medication doses were within recommended levels, and the interval from starting medication to onset of double vision was 9.6 days on average. Medication was discontinued in 53 patients, and diplopia resolved in all cases.

“Doctors need to be aware of this potential reaction when prescribing these antibiotics and consider stopping therapy if diplopia occurs,” Dr. Fraunfelder said. He also said that special care should be taken with patients who are older than 60, have had renal failure, or are taking steroids, and that thorough ophthalmic and neurological exams should be done to rule out other causes of double vision.

Till now, it was believed that tendinitis in the muscles around the eyes was responsible for double vision. The review findings are expected to provide great relief to patients suffering from this condition.

Tags: corneal transplant, diplopia, double vision, fluoroquinolones, steroids

Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids